Abstract
The goal of treatment of acute myeloblastic leukemia (AML) in children is cure. Treatment results in AML have considerably improved during the last decade [5]. Remission induction therapy has become increasingly successful, and approximately 70 to 80% of children achieved complete remission (CR). However, despite consolidation, intensification and maintenance therapy, relapses have become, at least for a certain group of children, the limiting factor in the efforts to increase the event-free-survival rate.KeywordsAcute Myeloid LeukemiaTotal Body IrradiationAcute GVHDAutologous Bone Marrow TransplantationAcute Myeloblastic LeukemiaThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
